Lombard Medical’s Aorfix endovascular stent graft has been featured in three presentations at the 2016 Japanese Society for Vascular Surgery Annual Meeting held in Tokyo, Japan.
The Aorfix endovascular stent graft was featured in the “Improving EVAR Treatment by using Aorfix” symposium chaired by Toshihisa Asakura, associate professor of the Department of Cardiovascular Surgery, Saitama Medical University International Medical Center (Saitama, Japan). Asakura comments, “I am very impressed by the unique design, flexibility and conformability of Aorfix. It has the only indication for use in standard and in challenging anatomies with highly angulated aortic necks. In my personal experience, it performs extremely well and the results are very encouraging.”
Naoki Toya, Vascular Surgeon at the Jikei University Kashiwa Hospital, Chiba, presented “Why I Use Aorfix” which addressed the Aorfix product design, the PYTHAGORAS clinical trial data, and his own series of 30 cases. Toya comments, “The global data on Aorfix is exceptional with results being equivalent to other stent graft technologies, despite the more challenging anatomies and sicker patients that tend to be treated with Aorfix. In my own series of 30 patients, there were no T1/T3 leaks or migration, with good sac shrinkage in more than 45% of cases at six month follow-up.”
Toya also presented the new IntelliFlex low profile delivery system anticipated for launch in Japan in early 2017. This presentation included a video of the “First-in-Man” case performed by Andrew Holden in Auckland, New Zealand, in November 2015.